4.6 Article

Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Transcriptional analysis of multiple ovarian cancer cohorts reveals prognostic and immunomodulatory consequences of ERV expression

Marina Natoli et al.

Summary: Baseline ERV expression in EOC can define clinically relevant subsets of patients and predict patient prognosis. High ERV score is associated with better survival and correlated with infiltration of CD8+PD1+T cells. Manipulation of ERV expression threshold can affect antitumor immunity.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Cell Biology

Dual EZH2 and G9a inhibition suppresses multiple myeloma cell proliferation by regulating the interferon signal and IRF4-MYC axis

Kazuya Ishiguro et al.

Summary: The study suggests that dual targeting of EZH2 and G9a in multiple myeloma can effectively inhibit tumor cell proliferation and xenograft formation, offering a promising therapeutic strategy.

CELL DEATH DISCOVERY (2021)

Article Oncology

Locus-Specific Characterization of Human Endogenous Retrovirus Expression in Prostate, Breast, and Colon Cancers

Margaret C. Steiner et al.

Summary: Research implicates that HERVs are involved in various cancers, with differential expression identified in prostate, breast, and colon cancers. The study highlights potential biomarkers and therapeutic targets in these cancers, providing insights into the role of HERVs in cancer pathogenesis.

CANCER RESEARCH (2021)

Article Oncology

Activating a collaborative innate-adaptive immune response to control metastasis

Lijuan Sun et al.

Summary: The combination of MPLA and IFNγ can polarize tumor-associated macrophages to kill cancer cells, reducing primary tumor growth and metastasis. This approach also enhances chemotherapy response and suppresses metastasis, with both macrophages and T cells playing critical roles in the anti-metastatic effects. Engaging a systemic anti-tumor immune response through activation of macrophages and T cells may represent a promising strategy for cancer treatment.

CANCER CELL (2021)

Article Oncology

Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trial

Bradley J. Monk et al.

Summary: The JAVELIN Ovarian 100 trial compared the efficacy of avelumab in combination with chemotherapy followed by avelumab maintenance, avelumab plus chemotherapy followed by avelumab maintenance, or chemotherapy alone in treatment-naive epithelial ovarian cancer patients. Results showed that avelumab did not demonstrate significant benefits in frontline treatment, suggesting the need for alternative treatment regimens to improve outcomes in advanced epithelial ovarian cancer patients.

LANCET ONCOLOGY (2021)

Article Cell Biology

Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING

Marine Bruand et al.

Summary: This study investigates mechanisms of inflammation and immunoreactivity in ovarian tumors with homologous recombination deficiency (HRD). BRCA1 loss leads to transcriptional reprogramming and inflammation involving type I interferon (IFN) and STING. Genetic deletion or methylation of DNA-sensing/IFN genes or CCL5 chemokine can attenuate T cell inflammation. Tumor-intrinsic STING elimination reduces neoangiogenesis and reverses therapeutic resistance to immune checkpoint blockade. VEFG-A blockade synergizes with STING loss and immune checkpoint blockade to control tumor growth in HRD cancers.

CELL REPORTS (2021)

Article Biochemistry & Molecular Biology

Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression

Cristina Segovia et al.

NATURE MEDICINE (2019)

Article Multidisciplinary Sciences

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Sarah Spear et al.

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2019)

Article Biochemistry & Molecular Biology

Interplay between EZH2 and G9a Regulates CXCL10 Gene Repression in Idiopathic Pulmonary Fibrosis

William R. Coward et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2018)

Article Multidisciplinary Sciences

Inhibition of Enhancer of zeste homolog 2 (EZH2) induces natural killer cell-mediated eradication of hepatocellular carcinoma cells

Suresh Bugide et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Medicine, Research & Experimental

Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma

Christof C. Smith et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Article Biochemical Research Methods

An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues

M. Ryan Corces et al.

NATURE METHODS (2017)

Article Multidisciplinary Sciences

Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden

Meredith L. Stone et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Biochemical Research Methods

MultiQC: summarize analysis results for multiple tools and samples in a single report

Philip Ewels et al.

BIOINFORMATICS (2016)

Review Oncology

Combining Epigenetic and Immunotherapy to Combat Cancer

Katherine B. Chiappinelli et al.

CANCER RESEARCH (2016)

Article Multidisciplinary Sciences

Mannose receptor induces T-cell tolerance via inhibition of CD45 and up-regulation of CTLA-4

Verena Schuette et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Review Multidisciplinary Sciences

Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

Vincenzo Bronte et al.

NATURE COMMUNICATIONS (2016)

Article Biochemistry & Molecular Biology

Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses

Katherine B. Chiappinelli et al.

Article Multidisciplinary Sciences

Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy

Dongjun Peng et al.

NATURE (2015)

Article Biotechnology & Applied Microbiology

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Michael I. Love et al.

GENOME BIOLOGY (2014)

Article Biochemical Research Methods

STAR: ultrafast universal RNA-seq aligner

Alexander Dobin et al.

BIOINFORMATICS (2013)

Article Chemistry, Medicinal

Discovery of an in Vivo Chemical Probe of the Lysine Methyltransferases G9a and GLP

Feng Liu et al.

JOURNAL OF MEDICINAL CHEMISTRY (2013)

Article Multidisciplinary Sciences

Evaluating cell lines as tumour models by comparison of genomic profiles

Silvia Domcke et al.

NATURE COMMUNICATIONS (2013)

Article Multidisciplinary Sciences

Integrated genomic analyses of ovarian carcinoma

D. Bell et al.

NATURE (2011)

Review Biochemistry & Molecular Biology

Keeping active endogenous retroviral-like elements in check: the epigenetic perspective

I. A. Maksakova et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2008)

Article Biotechnology & Applied Microbiology

Model-based Analysis of ChIP-Seq (MACS)

Yong Zhang et al.

GENOME BIOLOGY (2008)

Article Oncology

Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer

Feng Wang-Johanning et al.

INTERNATIONAL JOURNAL OF CANCER (2007)

Article Medicine, General & Internal

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

L Zhang et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Review Biochemistry & Molecular Biology

Gene structure and function of the 2′-5′-oligoadenylate synthetase family

J Justesen et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2000)

Article Biochemistry & Molecular Biology

KEGG: Kyoto Encyclopedia of Genes and Genomes

M Kanehisa et al.

NUCLEIC ACIDS RESEARCH (2000)